Try our Advanced Search for more refined results

October 13, 2016

Astellas Pharma Inc. et al v. Prinston Pharmaceutical Inc.

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. October 13, 2016

    Astellas Targets Generic Versions Of Bladder Drug Myrbetriq

    Astellas Pharma Inc. on Thursday filed three lawsuits in Delaware federal court seeking to block generic versions of its patent-protected overactive bladder treatment Myrbetriq, which were proposed by Aurobindo Pharma, Windlas Healthcare, Prinston Pharmaceutical Inc., Huahai US Inc. and Solco Healthcare US.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login